Retatrutide, developed by Soma Pharmaceuticals , is attracting significant attention as a novel method for weight control . This unique compound combines the activity of a GLP-1 receptor activator and a GIP receptor activator , aiming to simply promote metabolic improvements but also improve associated metabolic issues . Preliminary human trials… Read More